v3.26.1
Exclusive License Agreement (MDB Minnesota One) (Details Narrative)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2025
USD ($)
shares
Phase II clinical [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Payments for licensed products $ 250
Phase III clinical [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Payments for licensed products 1,500
New Drug Application First [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Payments for licensed products 2,000
New Drug Application [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Payments for licensed products $ 5,000
License Agreement [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Issuance of shares | shares 1,980
License fee $ 150